MAXCYTE INC's ticker is and the CUSIP is 57777K106. A total of 120 filers reported holding MAXCYTE INC in Q3 2023. The put-call ratio across all filers is 10.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $301,695 | -38.0% | 96,697 | -8.8% | 0.00% | -100.0% |
| Q2 2023 | $486,595 | +2.9% | 106,012 | +11.0% | 0.00% | 0.0% |
| Q1 2023 | $472,819 | -10.4% | 95,519 | -1.1% | 0.00% | 0.0% |
| Q4 2022 | $527,409 | -15.1% | 96,595 | +1.1% | 0.00% | 0.0% |
| Q3 2022 | $621,000 | +32.1% | 95,499 | -3.8% | 0.00% | 0.0% |
| Q2 2022 | $470,000 | -31.2% | 99,321 | +1.6% | 0.00% | 0.0% |
| Q1 2022 | $683,000 | -37.6% | 97,741 | -9.0% | 0.00% | 0.0% |
| Q4 2021 | $1,094,000 | +962.1% | 107,358 | +1168.1% | 0.00% | – |
| Q3 2021 | $103,000 | – | 8,466 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NORTH RUN CAPITAL, LP | 480,900 | $3,361,000 | 4.94% |
| Casdin Capital, LLC | 13,971,334 | $97,660,000 | 4.38% |
| Vitruvian Partners LLP | 4,385,670 | $30,656,000 | 3.25% |
| RIVER GLOBAL INVESTORS LLP | 2,100,000 | $14,849,000 | 1.95% |
| APIS CAPITAL ADVISORS, LLC | 180,000 | $1,258,000 | 1.52% |
| Pier Capital, LLC | 1,017,753 | $7,114,000 | 0.91% |
| First Light Asset Management, LLC | 1,321,406 | $9,237,000 | 0.82% |
| Montanaro Asset Management Ltd | 929,000 | $6,557,000 | 0.81% |
| Nicholas Investment Partners, LP | 776,963 | $5,431,000 | 0.39% |
| Bleichroeder LP | 250,000 | $1,764,000 | 0.31% |